We’re on the forefront of neutrophil alloantigen research and clinical diagnostics.
Neutropenia is a condition of abnormally low numbers of white blood cells (neutrophils). Versiti Diagnostic Labs performs antibody evaluations for Immune Neutropenia using only the most advanced diagnostic methods.
By combining high-sensitivity ELISA and flow cytometry methods, the Platelet and Neutrophil Immunology Laboratory at BloodCenter detects and identifies the specificity of antibodies.
Versiti Diagnostic Labs comprehensive suite of diagnostic testing options address diverse variations of neutropenia disease states. Often, neutropenia is caused by antibodies that bind to neutrophils and clear them out of circulation more rapidly than normal. Antibodies can form against neutrophil-specific alloantigens and neutrophil antigens shared with other cells. Neutrophil antibodies are important to consider in clinical conditions including neonatal alloimmune neutropenia, autoimmune neutropenia, and drug-induced neutropenia.
Comprehensive, highly specific diagnostic assays for your specific patient.
Versiti Blood Center of Wisconsin, boasts an internationally known laboratory that has always been on the forefront of clinical and scientific research in human neutrophil alloantigens. In fact, the molecular basis for HNA-3 was determined and reported by Dr. Brian Curtis, Sr. Director, Diagnostic Hematology at Versiti. We remain dedicated to leading these efforts and delivering the information physicians need to diagnose, treat and enhance the lives of their patients.
Autoimmune Neutropenia (AIN) - Primary AIN occurs in both adults and children as an isolated hematologic disorder not associated with other disease factors. Patients frequently present with neutrophil counts less than 500/mm3 and recurrent infections of mild to moderate severity. Neutrophil-reactive antibodies can be detected in the sera of patients with this disease, especially in children. Antibodies often show specificity for the HNA-1a antigen.
Neutrophil antibodies and AIN also occur as secondary phenomena in other autoimmune diseases including systemic lupus erythematosus, Felty's syndrome, rheumatoid arthritis, and myasthenia gravis.
Drug-induced Neutropenia - Flow cytometry has been shown to be effective in detecting some neutrophil drug-dependent antibodies. Many drugs including quinine have been implicated as causes of immune neutropenia.
Neonatal Alloimmune Neutropenia (NAN) - In NAN, the mother is immunized by fetal neutrophil antigens inherited from the father. Maternal lgG antibodies cross the placenta and destroy fetal neutrophils. The most common neutrophil alloantigen incompatibilities are HNA-1a/b/c and HNA-2. Unlike its erythrocyte counterpart, hemolytic disease of the newborn, NAN can occur during the first pregnancy and may occur once in every 500 live births. Antibodies can be detected in the maternal serum by testing with a panel of normal donor neutrophils. Testing with the father’s neutrophils is necessary to detect antibodies to low frequency antigens. Neutrophil genotyping of both parents can be useful for confirming maternal antibody specificity and in providing counseling regarding future pregnancies.
All Related Tests
Test for antibodies in patients serum that react against neutrophils only in the presence of a specific drug causing neutropenia.
This order set includes: Neutrophil Antibody Identification and HLA Antibody Detection.
This flow-cytometry screen tests for the detection and identification of neutrophil antibodies.
This order set includes: Neutrophil Antibody Screen and HLA Antibody Detection. Automatic reflexing options are available.
This DNA-based typing assay is for the HNA-1 Alloantigen system.
This DNA-based typing assay is for the HNA-3 Alloantigen system.
This DNA-based typing assay is for the HNA-4 Alloantigen system.
This DNA-based typing assay is for the HNA-5 Alloantigen system.